12059749 · Active · incorporated 7 years, 4 months ago · Oxfordshire
Biotech AI Biotech & Life Sciences Drug Discovery Generative AI Series B+
Etcembly uses AI and bioengineering to accelerate therapeutic innovation and design next-generation biologics, focusing on T Cell Receptor discovery.
Etcembly Ltd is a private limited company registered at Companies House under number 12059749, incorporated on 19 June 2019, with a registered office in Oxfordshire. Its current status on the register is active. Its filed nature of business is research and experimental development on biotechnology (SIC 72110). Sonde has indexed 69 filings for this company, including 6 funding rounds. Its most recent round closed in September 2025, raising £6m.
| Round | Closed | Raised | Price per share |
|---|---|---|---|
| Round 6 | Sep 2025 | £6m | £1.00 |
| Round 5 | Apr 2024 | £3.3m | £6.00 |
| Round 4 | Jun 2023 | £2.6m | £6.00 |
| Round 3 | Nov 2022 | £2.6m | £6.00 |
| Round 2 | May 2022 | £2m | £3.00 |
| Round 1 | Mar 2021 | £1.6m | £1.58 |
Showing the 11 most recent of 69 filings.
See the complete cap table with every shareholder, founder tags, dilution across 23 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.